Cresco Labs (CRLBF) Stock Price, News & Analysis

Company Overview

Cresco Labs Inc. is a vertically integrated cannabis company headquartered in Chicago, Illinois. Founded in 2013, the company cultivates, manufactures and distributes cannabis products for adult-use and medical markets in states where cannabis is legally permitted.

The company’s product portfolio includes flower, pre-rolls, vapes, concentrates, edibles and other cannabis products sold under brands such as Cresco, High Supply, Good News, Wonder Wellness, FloraCal, Remedi and Mindy’s Edibles. Cresco Labs also operates Sunnyside dispensaries, which sell cannabis products directly to consumers.

Cresco Labs serves multiple U.S. cannabis markets, including Illinois and other states with regulated adult-use or medical programs. Its operations generally span cultivation facilities, processing and manufacturing sites, wholesale distribution and retail dispensaries, allowing the company to participate in several stages of the cannabis supply chain.

Key Stats

• Today's Range: $0.62 to $0.65
• 50-Day Range: $0.63 to $0.82
• 52-Week Range: $0.59 to $2.30
• Volume: 178,368 shs
• Average Volume: 738,465 shs
• Market Capitalization: $239.72 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Strong Buy

Cresco Labs Stock Analysis - MarketRank™

Cresco Labs scored higher than 36% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.2 / 5
• Analyst Rating: Strong Buy

Consensus Rating

Cresco Labs has received a consensus rating of Strong Buy. The company's average rating score is 3.67, and is based on 2 strong buy ratings, 1 buy rating, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Cresco Labs has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Cresco Labs are expected to grow in the coming year, from ($0.04) to ($0.02) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Cresco Labs is -2.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Cresco Labs is -2.15, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Cresco Labs has a P/B Ratio of 1.29. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.29% of the float of Cresco Labs has been sold short.

Short Interest Ratio / Days to Cover

Cresco Labs has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Cresco Labs has recently increased by 5.48%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Cresco Labs does not currently pay a dividend.

Dividend Growth

Cresco Labs does not have a long track record of dividend growth.

News and Social Media

• Score: 4.1 / 5
• News Sentiment: 0.50

News Sentiment

Cresco Labs has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.39 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Cresco Labs this week, compared to 1 article on an average week.

Search Interest

19 people have searched for CRLBF on MarketBeat in the last 30 days.

MarketBeat Follows

6 people have added Cresco Labs to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Cresco Labs insiders have not sold or bought any company stock.

Percentage Held by Institutions

0.05% of the stock of Cresco Labs is held by institutions.

Company Calendar

• Last Earnings: 8/06/2026
• Today: 10/09/2026
• Next Earnings (Estimated): 11/05/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CRLBF
• CIK: 1832928
• Web: www.crescolabs.com
• Phone: 312-929-0993
• Fax: N/A
• Employees: 2,900
• Year Founded: 2013

Profitability

• EPS (Trailing Twelve Months): ($0.30)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$135.41 million
• Net Margins: -15.50%
• Pretax Margin: -15.92%
• Return on Equity: -7.53%
• Return on Assets: -1.68%

Debt

• Debt-to-Equity Ratio: 1.66
• Current Ratio: 1.78
• Quick Ratio: 0.98

Sales & Book Value

• Annual Sales: $655.85 million
• Price / Sales: 0.37
• Cash Flow: $0.04 per share
• Price / Cash Flow: 16.51
• Book Value: $0.50 per share
• Price / Book: 1.29

Miscellaneous

• Outstanding Shares: 372,350,000
• Free Float: N/A
• Market Cap: $239.72 million
• Optionable: Not Optionable
• Beta: 1.59